Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 3/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.61 |
| ▸ | PRKCA | P17252 | 1/20 | 0.61 |
| ▸ | SMG1 | Q96Q15 | 1/20 | 0.57 |
| ▸ | CAMK2D | Q13557 | 3/20 | 0.57 |
| ▸ | JAK2 | O60674 | 1/20 | 0.56 |
| ▸ | JAK3 | P52333 | 1/20 | 0.56 |
| ▸ | CDK2 | P24941 | 3/20 | 0.56 |
| ▸ | CDK4 | P11802 | 2/20 | 0.56 |
| ▸ | PLK1 | P53350 | 3/20 | 0.55 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.54 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.54 |
| ▸ | BCR | P11274 | 2/20 | 0.53 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.53 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.53 |
| ▸ | KDR | P35968 | 1/20 | 0.53 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.53 |
| ▸ | SRC | P12931 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2331086 | 0.87 | PIK3CG (0.70) | ABL1SMG1CAMK2DCDK2PLK1 | |
| SCHEMBL2322043 | 0.87 | PIK3CG (0.70) | ABL1SMG1CAMK2DCDK2PLK1 | |
| Hydrochloric Acid SCHEMBL16496538 | 0.86 | PIK3CG (0.69) | ABL1SMG1CAMK2DCDK2PLK1 | |
| SCHEMBL2328157 | 0.85 | CAMK2D (0.70) | ABL1PRKCDPRKCASMG1CAMK2D | |
| SCHEMBL27444158 | 0.84 | ABL1 (0.70) | ABL1PRKCDEGFRPRKCASMG1 | |
| SCHEMBL14253908 | 0.84 | ABL1 (0.59) | ABL1PRKCDEGFRPRKCASMG1 | |
| SCHEMBL27116599 | 0.84 | ABL1 (0.62) | ABL1PRKCDEGFRPRKCASMG1 | |
| SCHEMBL20776156 | 0.83 | ABL1 (0.56) | ABL1PRKCDEGFRPRKCASMG1 | |
| SCHEMBL2324992 | 0.83 | PIK3CG (0.76) | ABL1EGFRPRKCASMG1CAMK2D | |
| SCHEMBL1593016 | 0.82 | PRKCD (0.79) | ABL1PRKCDEGFRPRKCACAMK2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110294810-A1 | SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS | BAYER CROPSCIENCE AG (DE) | 2011-12-01 | — | — | US | claimed |
| CN-102216286-A | Substituted (pyridyl)-azinylamine derivatives as plant protection agents | BAYER CROPSCIENCE SA | 2011-10-12 | — | — | CN | claimed |
| US-20110294810-A1 | SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS | BAYER CROPSCIENCE AG (DE) | 2011-12-01 | — | — | US | disclosed |
| CN-102216286-A | Substituted (pyridyl)-azinylamine derivatives as plant protection agents | BAYER CROPSCIENCE SA | 2011-10-12 | — | — | CN | disclosed |
| EP-2356102-A1 | SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS | Bayer CropScience AG (DE) | 2011-08-17 | — | — | EP | disclosed |
| WO-2010055114-A1 | SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS | BAYER CROPSCIENCE SA (FR) | 2010-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294810-A1 | SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS | PRXL2A, AZI2, PIR | ABL1 801/4885PRKCD 4098/4885EGFR 4246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.